SIPONIMOD for Multiple sclerosis relapse: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 70 adverse event reports in the FDA FAERS database where SIPONIMOD was used for Multiple sclerosis relapse.
Most Reported Side Effects for SIPONIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 958 | 11.2% | 4 | 133 |
| Headache | 862 | 10.1% | 0 | 89 |
| Dizziness | 654 | 7.6% | 5 | 75 |
| Gait disturbance | 506 | 5.9% | 1 | 109 |
| Multiple sclerosis relapse | 504 | 5.9% | 4 | 132 |
| Fall | 478 | 5.6% | 4 | 166 |
| Multiple sclerosis | 455 | 5.3% | 11 | 85 |
| Lymphocyte count decreased | 398 | 4.6% | 2 | 84 |
| Nausea | 397 | 4.6% | 3 | 51 |
| Drug ineffective | 396 | 4.6% | 1 | 41 |
| Product dose omission issue | 381 | 4.4% | 0 | 86 |
| Covid-19 | 355 | 4.1% | 11 | 123 |
| Urinary tract infection | 352 | 4.1% | 9 | 193 |
| Asthenia | 343 | 4.0% | 4 | 90 |
| Pain | 322 | 3.8% | 0 | 52 |
Other Indications for SIPONIMOD
Multiple sclerosis (3,322)
Product used for unknown indication (2,592)
Secondary progressive multiple sclerosis (2,265)
Relapsing-remitting multiple sclerosis (519)
Relapsing multiple sclerosis (194)
Clinically isolated syndrome (147)
Primary progressive multiple sclerosis (60)
Progressive multiple sclerosis (20)
Progressive relapsing multiple sclerosis (7)
Other Drugs Used for Multiple sclerosis relapse
OCRELIZUMAB (373)
FINGOLIMOD (355)
METHYLPREDNISOLONE (291)
TERIFLUNOMIDE (216)
CORTICOTROPIN (173)
OFATUMUMAB (158)
ALEMTUZUMAB (155)
GLATIRAMER (133)
OZANIMOD (84)
CORTISONE (47)